Global Blood Therapeutics Inc
(NASDAQ : GBT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.77%89.331.3%$810.15m
AMGNAmgen Inc.
1.45%188.191.2%$638.11m
GILDGilead Sciences, Inc.
0.49%65.870.9%$484.65m
BIIBBiogen Inc.
0.88%323.981.3%$431.18m
ILMNIllumina, Inc.
1.40%301.023.5%$315.69m
REGNRegeneron Pharmaceuticals, Inc.
0.66%421.392.6%$292.10m
VRTXVertex Pharmaceuticals Incorporated
1.07%185.031.9%$256.31m
ALXNAlexion Pharmaceuticals, Inc.
1.04%128.872.0%$221.95m
SRPTSarepta Therapeutics, Inc.
2.07%139.3615.4%$155.48m
AAgilent Technologies, Inc.
0.08%77.951.6%$150.92m
EXASExact Sciences Corporation
8.64%90.4825.3%$143.71m
INCYIncyte Corporation
1.30%84.412.5%$113.39m
ARRYArray BioPharma Inc.
3.39%23.488.2%$111.67m
EXELExelixis, Inc.
0.80%21.396.4%$82.72m
NBIXNeurocrine Biosciences, Inc.
1.86%78.755.1%$78.66m

Company Profile

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.